DSE:SQURPHARMA Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	59,665	55,396	52,013	50,094	48,962	43,364
Cash & Short-Term Investments	59,665	55,396	52,013	50,094	48,962	43,364
Cash Growth	3.31%	6.50%	3.83%	2.31%	12.91%	33.16%
Accounts Receivable	2,281	2,236	2,551	3,421	2,159	1,636
Other Receivables	2,959	1,875	1,952	2,702	1,236	1,280
Receivables	5,240	4,111	4,503	6,122	3,395	2,916
Inventory	12,913	13,059	12,582	12,227	8,214	7,245
Prepaid Expenses	63.58	113.44	101.51	81.62	57.56	46.17
Other Current Assets	1,671	1,882	2,005	1,962	1,718	1,505
Total Current Assets	79,553	74,562	71,206	70,487	62,348	55,076
Property, Plant & Equipment	34,534	31,687	27,750	26,059	27,183	22,884
Long-Term Investments	47,718	40,566	33,682	25,270	22,227	17,492
Other Intangible Assets	-	0.03	0.05	0.11	-	-
Total Assets	161,805	146,815	132,637	121,816	111,758	95,452
Accounts Payable	1,285	1,375	1,455	1,002	625.98	666.17
Accrued Expenses	1,347	1,552	1,476	1,327	1,257	1,121
Current Portion of Long-Term Debt	512.49	625.5	614.54	618.61	200	-
Current Income Taxes Payable	1,935	1,307	912.27	356.1	911.5	572.68
Other Current Liabilities	11,724	964.58	823.65	926.1	666.85	818.87
Total Current Liabilities	16,804	5,823	5,282	4,229	3,662	3,179
Long-Term Debt	-	200	814.54	1,368	1,714	103.71
Long-Term Deferred Tax Liabilities	1,034	836.12	619.08	1,022	1,179	1,275
Total Liabilities	17,838	6,860	6,716	6,620	6,555	4,557
Common Stock	8,865	8,865	8,865	8,865	8,865	8,865
Additional Paid-In Capital	2,035	2,035	2,035	2,035	2,035	2,035
Retained Earnings	133,454	129,050	115,019	103,578	93,463	78,855
Comprehensive Income & Other	-394.07	-	-	717.6	839.61	1,139
Total Common Equity	143,960	139,950	125,919	115,196	105,203	90,895
Minority Interest	7.47	5.44	2.32	0.71	0.47	0.5
Shareholders' Equity	143,967	139,956	125,922	115,197	105,203	90,895
Total Liabilities & Equity	161,805	146,815	132,637	121,816	111,758	95,452
Total Debt	512.49	825.5	1,429	1,987	1,914	103.71
Net Cash (Debt)	69,961	64,616	59,877	52,697	51,395	47,885
Net Cash Growth	5.28%	7.92%	13.62%	2.53%	7.33%	35.82%
Net Cash Per Share	78.92	72.89	67.55	59.45	57.98	54.02
Filing Date Shares Outstanding	886.45	886.45	886.45	886.45	886.45	886.45
Total Common Shares Outstanding	886.45	886.45	886.45	886.45	886.45	886.45
Working Capital	62,748	68,738	65,924	66,258	58,686	51,898
Book Value Per Share	162.40	157.88	142.05	129.95	118.68	102.54
Tangible Book Value	143,960	139,950	125,919	115,196	105,203	90,895
Tangible Book Value Per Share	162.40	157.88	142.05	129.95	118.68	102.54
Land	-	8,851	8,486	6,632	6,446	6,136
Buildings	-	12,115	11,897	11,716	10,317	9,756
Machinery	-	34,177	30,559	29,322	26,788	25,510
Construction In Progress	9,275	2,983	1,318	1,083	6,388	2,460

Source: S&P Global Market Intelligence. Standard template. Financial Sources.